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Summary: The selective multitest Boehringer Mannheim/Hitachi 704 analysis System was examined according
to the ECCLS guidelines in a multicentre evaluation involving four laboratories. Ten routine parameters,
covering most of the application settings of the Instrument, were measured in the respective laboratory at
temperatures 25, 30 or 37 °C. The trial lasted four months and gave more than 40000 data. It yielded the
following results:
1. Within the four laboratories the mean coeffidents of Variation for three control sera at different concen-
trations were found to be equal to or better than 1.6% for the within-run imprecision and 2.8% or better
for the between-day imprecision.
2. No drift was observed during eight hours.
3. Because of the high linear measuring ränge a re-run analysis was seldom necessary.
4. 'Sample-related carry-over was not seen. Reagent-dependent carry-over was measured from cholesterol to
uric acid and from triacylglycerols to lipase. Through modification of the cholesterol and triacylglycerol
reagents, the carry-over effect was präctically eliminated.
5. The recovery of the assigned values of control sera showed average values between 99 and 104%. For
bilirübin, creatinine, creatine kinase and alanine aminotransferase some control sera showed deviations
greater than 10%.
6. In all cases, regression analysis of the resülts obtained in comparisons of the present Instrument with the
Hitachi 705 or 737 yielded slopes close to unity with extreme values of 0.95 and 1.06.
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7. During the entire evaluation period there was no malfunction or breakdown of the Instruments.
The evaluators came to the conclusion that the analytical performance äs well äs the reliability and practic-
ability of the Hitachi 704 can be rated äs excellent.
Introduction
To establish reliable performance criteria, the Boeh-
ringer Mannheim/Hitachi 704 analysis System1) was
evaluated in a multicentre study. Four clinical labo-
ratories participated in the evaluation. The evaluation
protocol mainly follows the ECCLS guidelines for the
evaluation of analysers in clinical chemistry (1). These
guidelines have already been applied successfully to
the multicentre evaluation of the Hitachi 737 (2).
This is the first time that a multicentre trial has been
undertaken at three different measuring temperatures.
This entailed a certain risk with regard to the com-
parability of the data, especially the enzyme activities.
To ensure uniformity between the different labora-
tories, similar Instruments (Hitachi 705 and 737 resp.)
were used for comparison.
These Instruments were chosen because of their wide
distribution together with their good performance and
acceptance. Moreover, these Instruments are already
installed for routine analysis in the four laboratories.
Within four months, more than 40 000 data had been
collected in the four centres and statistically evaluated
at Boehringer Mannheim.
Data were evaluated in four stages:
Familiarization period
The Instrument users were trained by experts of the
Company. An acceptance test was carried out covering
imprecision and inaccuracy with 3 control sera and a
minimum of 4 parameters.
Initial trial
An imprecision study was carried out for 10 days on
the Hitachi 704 and the comparison Instrument, using
the same 10 analytes äs in the main trial.
Main trial
Extensive performance data were obtained from the
main trial, which involved imprecision studies, recov-
ery studies, method comparisons, linearity studies,
carry-over and drift experiments for 10 analytes. In
contrast to the ECCLS-protocol, the within-run im-
precision was detennined only on one day instead of
three, and the between day impreqision data froin
both the initial and main trial were used.
Description of the Hitachi 704
The Hitachi 704 is a discrete, selectively operated
multitest analyser, which can handle up to 23 chemicäl
analytes including the electrolytes sodium, potassium
and Chloride; these are detennined with an optional
ion-selective electrode module. The Hitachi 704 was
developed äs a logical successor of the Hitachi 705,
offering additional special features: an alphanumeric
keyboard and improved printout, a real time qüality
control program, data monitoring and special Soft-
ware for immunological tests (non-linear curve fitting,
prozone check). A bidirectional link with a host Com-
puter is possible.
The Hitachi 704 is available in 4 versions: a basic
model with 37 °C measuring temperature only, a
model with cooling unit and three measuring temper-
atures (25, 30, 37 °C) and both of these versions with
an ISE-unit. For the multicentre evaluation the model
with cooling unit was used. ISEs were tested in a
different laboratory; the results will be püblished else-
where. The Instrument specificiations are listed in
table 1; figure l shows the analysis modes of the
Hitachi 704. For easy reagent handling special System




The reagents used on the Hitachi 704 and the comparison
analysers are listed in table 3; table 4 shows the most important
application settings. The control sera used in the respective
trials are shown in table 5.
The four participants of the multicentre evalutation used the
same lot of reagent for each of the ten methods.
Predetermined factprs were used in the estimation of enzyme
activities; a reagent blank was run daily. The factors were the
mean of 5 calibration runs using the calibrator for automated
Systems (Lot. No. 1512662)). With the exception of bilirubin,
all other Substrates were calibrated with a daily freshly prepared '
calibrator. For the bilirubin assay a fixed factor was detennined
by 5 calibration runs with the Precibil® control $erum (tab. 5).
Measurements were performed at 37 °C in laboratories l and
3, at 30 °C in laboratory 4 and at 25 °C in laboratory 2.
0 Abbreviated to Hitachi 704 in the following text. 2) Cat. No. 608432* Boehringer Mannheim GmbH.
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20; with optional ISE-module 23.
Endpoint, endpoint with sample blank, kinetic with serum or Substrate start, fixed-time kinetic,
combination of two endpoint tests, endpoint and kinetic tests, two kinetic tests, performing
two tests in one cuvette, two prozone check procedures, ISE, linear and non-linear calibration,
isoenzyme calibration, serum-indices (indicating haemolytic, lipaemic and icteric specimens).
180 tests, with ISE 360 tests, additionally 60 tests with a TWIN-test reagent (two tests in one
cuvette).
Turntable with 90 positions in total
— 40 in the outer ring for routine samples
— 30 in the middle ring for standards/calibrators
- 20 in the inner ring for control material, ISE calibrator, stat samples and washing solution
Sample cups with 2 ml maximum volume can be used. The minimum sample volume depends
on the number of requested tests, on average 50 μΐ.
3-20 μΐ per test, 20 μΐ for ISE.
Imprecision < 1%.
Optional. Gold water circuit, refrigerator temperature 5-15 °C.
23 and 50 ml sizes.
l reagent pipettor for dispensing reagents l and 2: 50-500 μΐ.
l stirrer mixes the reaction solution after addition of reagents l and 2.
Turntable; one rotation (49 cuvettes + 1) in 20 seconds = l working cycle.
48 polyacryl cuvettes, disposable. Volume required: minimum 350 μΐ, maximum 700 μΐ. Optical
path length: 6 mm. %
10 minutes; addition of reagent 2: 5 minutes after reagent 1.
Water bath 37 ± 0.1 °C. With cooling unit 25, 30 and 37 °C.
o Single beam photometer with 11 available wavelengths: 340, 376, 415, 450, 480, 505, 546,
570, 600, 660 and 700 nm; mono- or bichromatic measurement with freely selectable wa-
velength combination.
o Light source: halogen lamp.
o Wavelength adjustment: fixed, via a grating chromator, inaccuracy < 2 nm.
o Half band width: 4 nm in the UV r nge
10 nm in the visible r nge.
o Photoinetric r nge of linearity: A = 0 — 2.5.
o Photometric resolution: A = 0.0002.
o Photometric inaccuracy: max. 1%.
o Indirect p tenti metry; flow-through electrode with liquid membrane.
o Reference electrode: Ag/AgCl.
o Dilution ratio l : 31.
o Incubation temperature 37 ± 0.1 °C, with cooling unit 25, 30, 37 °C.
o Calibration: autpmatic 2-point.
o Measuring fange: Na+ 80—180 mmol/l^
K+ 1.5-10mmpl/l,
Cl- 60-120mmol/L
o Interface: RS 232 C. Bidirectional link with a host Computer is possible.
o Data input: via alphanumeric keyboard and item select keys.
o Data control: CRT-display, 12 inches.
o Data Output: printer, 80 characters/lme.
o 2 Floppy disks, 51/4 inches, 1.6 M bytes, l System disk and l data disk for 400 samples
and 40 stats.
o Reaction nionitor for 50 tests.«
Internal reservoir with an external supply,
Quality: ^ l μ8,
Consumption during Operation: 10 l/h.
15-27°C.
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Fig. l. Analysis modes of the Hitachi 704
s = sample
Rl, R2: reagent l, 2
Ml, M2: mixing l, 2
Pi = reading points
*) correction for test 2
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For some analytes, several methods are available.
ceeded directly the initial trial, and both studies were performed
under the same conditions, the d ta of both trials were cpm-
bined to obtain 21 single data3). Only the second value of the
duplicate measurements was taken for the statistical calculation.
Drift
Drift effects were st died for all the ten analytes with the same
three control sera used in the irnprecision trial. Several vials
from the same lot were pooled and kept in closed Containers
in a refrigerator. Small portions were transferred into the sample
cups of the analyser 15 minutes before the measurements which
were taken hourly over a period of 8 hours. For the bilirubin
assay the control material was reconstituted every 2 hours to
avoid stability problems of the analyte.
Measuring r nge and linerarity
The measuring r nge and the linearity of the methods were
checked by mixing a high level serum — which in some cases
had to be spiked — with a low level serum to obtain a series
of 10 different concentrations. Fresh reagents were used. The
measurements were made on two different days.
Imprecision
For the within-run imprecision study three different control
sera containing three different levels of the corresponding an-
alyte were used (tab. 6). Each participant carried out 21 deter-
minations with each of the analytes. Additionally two fresh
human serum pools with different levels of the analytes were
measured.
The same control sera were used to establish the between-day
imprecision with the Hitachi 704 and the comparison.methods.
As the between-day imprecision study of the main trial suc-
Carry-over
The carry-over caused by the sample probe was st died in detail
according to a model of roughton (18). Five successive portions
of a specimen with a high value (ht ..., hs) folloWed by 5
suceessive portions of one with a low value (l, ..., ls) were
determined ten times for each of the analytes.
3) Twenty days in laboratory l, and eleven days in laboratofy
4 for the comparison instrument Hitachi 705.
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Tab. 3. Reagcnts used during the multicentre evaluation.


















































































*) "optimized Standard method" conforming to the recommendations of the Deutsche Gesellschaft f r Klinische Chemie.


















































































































') kin = kinetic mode, EP
2) decr. = decreasing, incr.
3) 10 μΐ at 37 °C
Endpoint, con = continuous mode
= increasing
A c rryrpver constant can be calculated according to the fol-
lowing relation;
K = roeana.-t?)
mean (h5 - 15)
Reagent-related ca.rry-over can be caused by the reagent pipet-
ti g System, the stirrer an<l th? cuvettes. Carry-over from the
lactate dehydrogenase of the alanine aminotransferase assay to
the lactate dehydrogenase assay caused by reagent sampling
was checked in one centre. Reagents A and B were pipetted
alternately, where represents the alanine aminotransferase
and B the lactate dehydrogenase. For this experiment only, the
reagent containing the lactate dehydrogenase (about 3000 U/l;
A 1) was pipetted before reagents l and 2 of B.
Similar studies with other reagent combinations such s cho-
lesterol-uric acid and triacylglycerols-lipase were carried out by
the evaluation group of Boehringer Mannheim, and are dis-
cussed in the Results section.
Comparison of the analytical procedures
Accuracy was examined by 3 experiments:
Mean values obtained in the between-day imprecision study
were compared:
a) with the assigned values of the three control sera and
b) with the mean value of the comparison method.
J. Clin. Chem. Clin. Bipchem. / Vol. 25,1987 / No. 12
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*) The Precinorm® U 151621, Precipath® EV 704 and Preci-
path® U 151 464 were used s control sera l, 2 and 3 in the
imprecision and recovery studies.
In a second experiment, up to 25 different control sera (de-
pendent on the analyte) were measured in duplicate assays with
the Hitachi 704 and the comparison method. The recoveries of
the assigned value were calculated and compared with those
for the comparison method.
Each of the 4 laboratories analysed 100 fresh human sera (10
sera per day for 10 days), covering the entire analytical r nge
for each of the 10 analytes with the Hitachi 704 and the
comparison Instrument. Both metbods were measured in par-
allel.
Results
The ten methods were not chosen arbitrarily but were
selected with a view to checking s many application
settings of the Instrument s possible (e.g., wave-
length, measuring points, sample and reagent volumes
and reaction course). Nearly all performance criteria
of the Instrument are covered by these ten analytical
methods.
Imprecision
Figure 2 shows the Condensed data for the within-run
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Fig. 2. Within-run imprecision of 4 laboratories and 3 control
sera.
For assigned values of the control sera see table 6.
CV = coef cient of Variation
* = median of the CV's
0 α = r nge of the CV's
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The asterisks respresent the median and the blocks
the r nge of the coefficients of Variation4) for all
laborat ries and control sera. The median of the CV
for all 10 analytes is equal to or better than 1.6%.
Only for alanine aminotransferase, γ-glutamyltrans-
ferase and uric acid does the CV exceed 2% (2.5%,
2.3% and 3.2% respectively).
Similar results were obtained for the within-run im-
precision in human sera. Table 7 shows the data for
a normal and pathological serum obtained by the
laborat ries measuring at 37 °C.
Tab. 7. Within-run iinprecision in human sera with the Hitachi


































































For the same control sera, figure 3 shows the CV of
the between-day imprecision study for the Hitachi 704
and the comparison instrument. The CV is below 3%
exeept for alanine-=aminotransferase (3.1%), bilirubin
(6.5%), urea (3,5%) and uric acid (3.9%). The median
of the CV is around 2% (2.8% for bilirubiri and 0.7%
for amylase).
Figure 4 gives a more detailed presentation of the
between-day imprecision data for the control sera l
and 3, for one laboratory in each case. The impreci-
sion of the Hitachi 704 is remarkably better than that
of the comparison Instruments. This may be the case
if a new instrument is compared with one that has
been in routine use for years.
Alanine aminotransferase
Creatine kinase








4) Abbreviated to CV in the following text.
1 2 3 4 5 6
CV [%)
Fig. 3. Between-day imprecision of 4 laborat ries and 3 control
sera for the Hitachi 704 and the comparison Instrument.
For assigned values of the control sera see table 6.
CV = coefficient of Variation
* = median of the CV's for the Hitachi 704
o = median of the CV's for the comparison Instrument
D = r nge of the CV's, upper block for the Hitachi
704, lower block for the comparison Instrument
The relatively high CV (maximum 6.5%) of bilirubin
reflects the instability of this analyte: the bilirubin
value is dependent on the influence of light and the
reconstitution time of the control serum. Therefore it
lends itself poorly to instrument testing unless pre-
analytical conditions (mainly reconstitution and stor-
age) are standardized.
Drift
All data have been represented graphically. Only bil-
irubin in one laboratory shows a severe drift because
the pre-analytical conditions were not maintained.
For all other methods no drift was found. Figure 5
illustrates the excellent reproducibility for amylase
and cholesterol over 8 hotirs.
Measuring r nge and linearity
The linearity study for alanine aminotransferase at
37 °C is shown in figure 6. In the left-hand diagram
the measured activity is plotted against the target
activity, which is obtained by regression calculation
of the first 4 points, this being the segment more likely
to be linear. The higher values tend to deviate more
and more from the identity y = χ. Α better critical
examination is possible for the right-hand diagram
which shows the relative deviation of measured and
expected values. The acceptance criteria for linearity
was set at a limit of ± 5% from the expected value.
J. Clin. Chem. Clin. Biochem. / Vol. 25,1987 / No. 12
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Fig. 5. Eight-hour drift-experiment; recovery of -amylase and
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Fig. 4. Between-day imprecision in each laboratory
704 and comparison Instrument).
For assigned
D
(Hitachi ilirubin 30 μιηοΙ/1 360 ^ 360




705 (Lab. 2: Hitachi 737)
Cholesterol 25 mmol/1 25 > 25
Creatinine 25 μηιο1/1 2100 £ 2100
Triacylglycerols 25 mmol/1 13 ^ 1 3
In the given
700 U/l, i.e.
example the 5% deviation is attained at Urea
the method is linear up to 700 U/L
37 inmol/1 57 47
Uricacid 25 μιηοΐ/ΐ 1370 1000
Table 8 summarizes the results of the linearity exper-
iment. The measuring r nge is shown in the last
column while the preceding column represents the
values up to which the linearity has been checked. A
wide linear measuring r nge was found, seldom re-
quiring sample predilution.
Because the linearity was checked with fresh reagents,
the linearity limits were even higher than those
claimed by the manufacturer.
*) freshly prepared reagents. For the Substrates only the highest
tested linearity is presented.
Carry-over
Table 9 shows results ffom the inVestigation of sam-
ple-related carfy-over. Only the highest carry-over
recorded by any laboratory for an analyte is reported
in this table. The minimal and maximal values f the
J. Clin. Chem. Clin. Biochem. / Vol. 25,1987 / No. 12
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Fig. 6. Linearity of alanine aminotransferase at 37 °C (lab. 1).































































































































J) median of the ten values of 13, U and 15
2) n = 30
difference li —15 s well s the median of the ten series
are reported. In all cases the median is less than the
Standard deviation of the low concentration. If the
maximal value of the difference li—15 is compared
with the 90% r nge of the low concentration, the
difference is lower than the r nge, except for triacyl-
glycerols (twice the r nge). But this poor result for
triacylglyeerols was found in only one of the ten series,
so that the occurrence of systematic carry-over cannot
be claimed.
We think that the comparison of the interference effect
with the impre sion of the uninfluenced low values
is more illustrative than the carry-over constant. As
the carry-over effect is within the npise level of the
detennination of the respective analyte, the diiference
often becomes negative.
Reagent-dependent carry-over for the coinbination
alanine aminotransferase to lactate dehydrogenase is
negligible, values showing less than 10 U/l at 37 °C,
i. e. less than 3% of the reference limit.
A carry-over caused by both the reagent pipettor and
the cuvettes was found with the System cholesterol to
uric acid. The uric acid results are increased by about
7.8 μιηοΐ/ΐ at 37 °C, if this assay is performed after a
cholesterol assay, or in a cuvette which has previously
been used for a cholesterol test. The cholesterol oxi-
dase is responsible because it affects the colorimetric
reagent of the uric acid test. Boehringer Mannheim
has modified this enzyme, so that the carry-over is
now negligible.
The lipase result is increased about 600 U/l if a lipase
assay is performed after a triacylglycerol test. This is
due to the lipase activity of the triacylglycerol reagent.
In the past it was recommended that the lipase assay
should be run in batch-mode and with a separate
cuvette ring. The latter is not necessary if the triacyl-
glycerol test is programmed so that the reaction takes
place in the first 5 minutes of the reaction cycle and
then hydrochloric acid is added to deactivate the
lipase in the reaction mixture. The sample carry-over
J. Clin. Chem. Clin. Biochem. / Vol. 25,1987 / No. 12
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can be avoided, if both channels are separated frora
each other and a lipase assay is never requested after Α(αηβ|εηΤΓν^ΓαεΗθη °
a triacylglycerol test. Taking these points into consid- aminotransferase
eration the lipase assay can then be performed in the ^^^^
usual selective mode. o-Amyiase
Bilirubin
Cholesterot
Comparison of analytical procedures Creatinine
r Urea
Recovery of the assigned value in control samples Triacyigiycerois
Uric acid
Figure 7 shows the recovery of assigned values for
· j r* i_ Alaninecontrol serum 1 . These results were obtainea irom the aminotransf erase
mean of the between-day imprecision (n = 20 or 21; Creatine kinase
_ , Α χ ^ , .- γ-Glutamyltransferase2nd of the duplicate measurements). Only the urea a-Amyiase
and uric acid recoveries in laboratories 2 and 3, re- Bilirubin
spectively, are clearly outside the + 5% limit, al- choiesteroi
though they are within the ± 10% r nge. Similar ^^α
results were found with the other two control sera. Triacyigiycerois
Table 1 0 summarizes the results of the recovery studies Unc QCld
in 25 different control sera. The mean recovery (me- as
J* \ · 1 Λ. ΛΓ\ί\ί\/ £ —.11 __.~1-.4. — .~ ,·.,!Λ.Λ~.
Lab.1 Lab, 3















































>0 1.00 1.10 0.90 1.00 1.1
Lab.2 Lab. 4dian) is very close to 100% for all analytes with
extreme values ctf 99 and 104%. Hence the majority
of deviations from the assigned value is within ± 5%.
A more marked deviation can be seen in the case of
creatine kinase, with 7% of the values (4 labs with 20
to 25 sera) deviating more than 20% from the as-
signed value. This is possibly due to the specific com-
position of control sera from different sources, and
the dependency on the reconstitution time. The de-
viations (more than 10%) in the case of bilirubin can
be explained by the instability of the analyte. The
target value of creatinine is dependent on the method.
For both analytes the agreement with the comparison
• Instrument is good.
It should be mentioned that these results were estab-
lished by a single experiment, whereas the mean of
several independent series should be chosen for the
examination of the accuracy.
Fig. 7. Recovery of assigned values for control serum l (lab. l
to4).
Method comparison with patient specimens
The statistical evaluation by a non-parametric method
of Passing & Bablok (19, 20) yielded slopes for the
regression line which are close to unity in all cases
with extreme values of 0.95 and 1.06. The intercepts
are negligible (see tab. 11). The medians of the rela-
tive differences do not show any significant deviations
from the comparison method. The results reflect close
agreement with the comparison Instrument, i.e. the
established laboratory method.
Plots for the comparison of methods are shown in
figure 8. To improve the graphical presentation, not
all figures show the whole measuring r nge.
Tab. 10. Recovery in 25 different control sera.
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Tab. 11. Mcthod comparison with human sera on thc Hitachi 704 (y) and comparison Instrument (x) (Hitachi 705, Lab. l, 3, 4
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Since the multicentre evaluation was primarily con-
cerned with the Hitachi 704 Instrument and not with
the reagents applied to it, interference studies were
not carried out.
Assessment of practicability
In addition to the analytical perfofmance, character-
istics such s reliability, practicability and Integration
into the laboratory Organisation are important for the
evaluation of an analytical Instrument. These attri-
butes cannot be measured accurately and no general
evaluation protocol can be applied. Nevertheless,
these points should be observed during the evaluation
period. Only a brief summary of the impressions will
be presented in the following.
No problems were associated with the Installation of
the Hitachi 704. The laboratory staff was well ac-
quainted with the Instrument within two days, which
is normal for an operator with experience on other
Hitachi analysers. The Instrument can be operated
easily, and the data input is very simple. However,
the characters of the keyboard are arranged alpha-
j. Clin. Chem. CUn. Biochem. / Vol. 25,1987 / No. 12
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Alanine aminotransferase [U/ l ]







Lab. 3 37 eC y · x
l l
Lab. 4 30 °C y » χ
Creatine kinase [U/11
l. 37 »c y = χ
Hitachi 705
Lab. 2 25 «C y = χ
Hitachi 737
lab. 3 37 «C y * χ
lab. 4 30 eC y « χ
'i1'"!.""!
t-Glutomyltronsferase l U/11
lab. 1 37 "C y « χ
lab. 2 25 °C y » χ
lab. 3 37 °C y - χ
Lab. 4 30 °C y » χ
l l l
a-Amylase [U/l]
leb. l 37 "C y · χ
Hitachi 705
Lab. 2 25 °C y - χ
Lab. 3 37 °C y « χ
4 30 °C y β χ
Bilirubin (μπιοΙ/Π
Lab. 1 37 «C y » χ
_J l l
lab. 2 25 "C y > χ
lab. 3 37 °C y · χ
Lab. 4 30 «C y · χ
Cholesterol [mmol / l ]
Lab. l 37 *C y · χ
Lab. 2 25 °C y - χ
r* ' ' ' i ' ' ' '
Hitachi 737
Lab. 3 37 «C y « χ
4 30 «C y · χ
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Creatinine ΙμιηοΙ/Π
b. 1 37 *C y · χ
HHecM 705
b. 2 25 *C y · χ
Hitachi 737
b. 3 37 *C y · χ
Hitachi 705
lab. 4 30 «C y · χ
Ureo Immol/l]
lab. 1 37 ·€
Hitachi 705
Hitachi 737
b. 3 37 «C y «
b. 4 30 *C y · χ
Triacylglycerols tmmol/1]
lab. l 37 C~
tab. 2 25 *C
lab. 3 37 "C y " χ
Lab. 4 30 «C
Hitachi 705
Uric ocid Ι μ Γ η ο Ι / Ι ]
lab. \ 37 "C
Ub. 2 25 «C
HUacM 737
b. 3
Fig. 8. Method comparison from 4 laboratories.
betically, which is unusual for users who are famili r
with the* conventional typewriter keyboard. On the
other band, one can easily get accustomed to this
arrangement.
For the frequently requested analytes the reagent bot-
tles are too small for longer series. Boehringer Mann-
heim will introduce concentrated reagents for more
than ten methods so that at least twice the number
of determinations per bottle can be made.
The ECCLS-protocol recommends a logbook in
which any breakdown or defect of the Instrument is
recorded. In our case, keeping this logbook was not
actually necessary. There were no breakdowns in any
of the laboratories at any time during the entire eval-
uation period. Only during the initial trial in labora-
tory 4, was there a problem with the light source of
the photometer. This was recognized from the results
of the day^to-day imprecision run. After exchange of
the l mp, this Instrument ran without any fault.
Reliability and practicability, s well s the analytical
Performance of the Hitachi 704, can be rated s ex-
cellent. The Hitachi 704 is well suited for routine
Operation and emergency analysis in small to medium-
sized lab ratories,and s a back-up System for large
laboratories.
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